J. H. Kim

In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.

D. Kirn, J. H. Kim, S. Freytag, 2000, Cancer research.

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization.

J. H. Kim, S. Freytag, M. Wing, 2000, Human gene therapy.

Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.

S. Kim, J. Kim, S. Freytag, 1997, Human gene therapy.

Estramustine: a novel radiation enhancer in human carcinoma cells.

S. Ryu, Y. Lee, S. Kim, 1994, International journal of radiation oncology, biology, physics.

Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown.

C. Song, R. Griffin, Stephen Brown, 1999, Cancer research.

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy.

J. H. Kim, S. Freytag, D. Paielli, 1998, Human gene therapy.

Radiation-induced senescence: therapeutic opportunities

M. Gordon, S. Brown, Jae Ho Kim, 2023, Radiation Oncology.

Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.

S. Kim, J. Kim, S. Freytag, 1995, International journal of radiation oncology, biology, physics.

Mitigation of radiation‐induced skin injury by AAV2‐mediated MnSOD gene therapy

J. H. Kim, Stephen Brown, S. Freytag, 2008, The journal of gene medicine.